3P Biopharmaceuticals is a CMO with capability to develop and manufacture recombinant proteins for therapeutic uses, in adequate quantities and quality for preclinical and clinical trial phases I, II, III and commercial stages. It also offers development of products and processes necessary for cellular and gene therapy, and recombinant proteins for non-therapeutic uses.